Edition:
United States

CVS Health Corp (CVS)

CVS on New York Consolidated

79.76USD
21 Feb 2017
Change (% chg)

$0.07 (+0.09%)
Prev Close
$79.69
Open
$79.61
Day's High
$80.39
Day's Low
$79.13
Volume
6,280,996
Avg. Vol
8,267,262
52-wk High
$106.67
52-wk Low
$69.30

CVS

Chart for CVS

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $81,809.80
Shares Outstanding(Mil.): 1,025.70
Dividend: 0.50
Yield (%): 2.51

Financials

  CVS Industry Sector
P/E (TTM): 16.18 19.37 40.61
EPS (TTM): 4.93 -- --
ROI: 7.74 11.82 59.88
ROE: 14.30 13.37 67.63

CVS removes artificial trans fats from its food brands

CVS Health Corp said its pharmacy chain had removed artificial trans fats, which have been linked to rising rates of heart diseases, from its store-branded food products well ahead of a June 2018 federal deadline.

Feb 22 2017

CVS removes artificial trans fats from its food brands

Feb 22 CVS Health Corp said its pharmacy chain had removed artificial trans fats, which have been linked to rising rates of heart diseases, from its store-branded food products well ahead of a June 2018 federal deadline.

Feb 22 2017

CVS defends PBM industry against drug price hikes

Drugstore chain and pharmacy benefits manager CVS Health Corp defended the industry on Thursday, saying any suggestion that PBMs are causing drug prices to rise was "simply erroneous".

Feb 09 2017

UPDATE 3-CVS defends PBM industry against drug price hikes

* Q4 revenue rises 11.7 pct to $45.97 bln vs. est. $46.50 bln

Feb 09 2017

BRIEF-CVS Health reports Q4 adj. EPS $1.71

* Qtrly same store sales decreased 0.7 pct versus prior year, with pharmacy same store sales up 0.2 pct

Feb 09 2017

CVS Health quarterly revenue rises 11.7 pct

Feb 9 Drugstore chain and pharmacy benefits manager CVS Health Corp reported an 11.7 percent rise in quarterly revenue on Thursday, helped by strength in its PBM business.

Feb 09 2017

Pharmacies lose class status bid in antitrust lawsuits against Caremark, Express Scripts

Independent pharmacies that have brought lawsuits accusing pharmacy benefit managers CVS Caremark and Express Scripts of conspiring to pay them less than chain pharmacies cannot bring their claims as class actions, a federal judge has ruled.

Jan 19 2017

CVS slashes price of Impax's EpiPen rival

Drugstore chain CVS Health Corp has cut the price of a generic version of Impax Laboratories Inc's emergency allergy injection, a device similar to Mylan NV's controversial EpiPen.

Jan 12 2017

CVS slashes price of Impax's EpiPen rival

Drugstore chain CVS Health Corp has cut the price of a generic version of Impax Laboratories Inc's emergency allergy injection, a device similar to Mylan NV's controversial EpiPen.

Jan 12 2017

CORRECTED-UPDATE 1-CVS slashes price of Impax's EpiPen rival

Jan 12 Drugstore chain CVS Health Corp has cut the price of a generic version of Impax Laboratories Inc's emergency allergy injection, a device similar to Mylan NV's controversial EpiPen.

Jan 12 2017

More From Around the Web

Earnings vs. Estimates